| Cvs Pharmacy # 05025 | |
| 1875 Capital Cir Ne, Tallahassee, Florida 32308 | |
| (850) 216-2244 |
| Name | Cvs Pharmacy # 05025 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 1875 Capital Cir Ne, Tallahassee, Florida 32308 |
| Type | Pharmacy |
| Phone | (850) 216-2244 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Chronic fatigue syndrome (CFS) may be alleviated by the anti-cancer drug Rituximab, suggesting that the source of the disease could lie in the immune system, according to a new study published Oct. 19 in the online journal PLoS ONE.
Each year thousands of patients undergo total hip replacement surgery in order to help alleviate pain associated with debilitating hip disease and other related hip problems.
Patient Safety Technologies, Inc. today announced the closing of a $7.1 million common stock financing. The investors, led by a new institutional investor, together with several existing shareholders and certain members of senior management, purchased 9.48 million shares of common stock at a price of $0.75 per share.
Scientists at the Centre for Addiction and Mental Health have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord related to MS, and a way to alter this change to reduce the nerve cell damage that occurs with the disease.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 5 days ago
| NPI Number | 1770687634 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY 05025 |
| Type | Pharmacy |
| Address | 1875 Capital Cir Ne, Tallahassee, FL 32308 |
| Phone Number | 850-216-2244 |
News Archive
Chronic fatigue syndrome (CFS) may be alleviated by the anti-cancer drug Rituximab, suggesting that the source of the disease could lie in the immune system, according to a new study published Oct. 19 in the online journal PLoS ONE.
Each year thousands of patients undergo total hip replacement surgery in order to help alleviate pain associated with debilitating hip disease and other related hip problems.
Patient Safety Technologies, Inc. today announced the closing of a $7.1 million common stock financing. The investors, led by a new institutional investor, together with several existing shareholders and certain members of senior management, purchased 9.48 million shares of common stock at a price of $0.75 per share.
Scientists at the Centre for Addiction and Mental Health have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord related to MS, and a way to alter this change to reduce the nerve cell damage that occurs with the disease.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 5 days ago
News Archive
Chronic fatigue syndrome (CFS) may be alleviated by the anti-cancer drug Rituximab, suggesting that the source of the disease could lie in the immune system, according to a new study published Oct. 19 in the online journal PLoS ONE.
Each year thousands of patients undergo total hip replacement surgery in order to help alleviate pain associated with debilitating hip disease and other related hip problems.
Patient Safety Technologies, Inc. today announced the closing of a $7.1 million common stock financing. The investors, led by a new institutional investor, together with several existing shareholders and certain members of senior management, purchased 9.48 million shares of common stock at a price of $0.75 per share.
Scientists at the Centre for Addiction and Mental Health have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord related to MS, and a way to alter this change to reduce the nerve cell damage that occurs with the disease.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 5 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2777 Miccosukee Rd 4, Tallahassee, Florida 32308 Phone: (850) 383-1188 | |
Bailey's Medical Equipment And Supp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3163 Eliza Rd, Tallahassee, Florida 32308 Phone: (850) 765-5795 | |
Publix Pharmacy #1306 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3521 Thomasville Rd, Tallahassee, Florida 32309 Phone: (850) 893-1143 | |
Cvs Pharmacy # 04024 Type: Pharmacy Location: 5466 Thomasville Rd, Tallahassee, Florida 32312 Phone: (850) 893-8116 | |
Cvs Pharmacy # 05025 Type: Pharmacy Location: 1875 Capital Cir Ne, Tallahassee, Florida 32308 Phone: (850) 216-2244 |